The Chemours Company (NYSE:CC) shares are plummeting today after the company reported preliminary results, disclosed management changes, and further delay in filing its 10-K.
Preliminary results: The company expects FY23 net sales of about $6.0 billion (vs. $6.8 billion a year ago), compared to the consensus of $6.02 billion.
Revenue declined Y/Y owing to lower volumes in Titanium Technologies and Advanced Performance Materials’ Advanced Materials portfolio.
Also, Chemours expects to report a net loss attributable of $(225) million to $(235) million versus a net income of $578 ...